article thumbnail

Lilly has a new blockbuster

World of DTC Marketing

Mounjaro, Lilly’s new diabetes drug, is sure to be in high demand initially after launch, but patients should be aware of its side effects. According to Lilly side, the effects include “Mounjaro may cause tumors in the thyroid, including thyroid cancer and Inflammation of the pancreas (pancreatitis).”

article thumbnail

OSD contract manufacturing market valued at $54.7 billion by 2030

European Pharmaceutical Review

billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Data showed that worldwide, oral solids are the most popular mode of drug delivery due to being highly cost-effective and offering simple manufacturing processes. This is especially beneficial as a way of decreasing potential side effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . It has to persuade patients to sign up for some heinous side effects.

article thumbnail

The future of pharma depends on its employees

World of DTC Marketing

By 2030, low retention will, on average, cost the US $430 billion annually. The title-seeking job hoppers will always be a pharma side-effect, but who within the big matrix organizations are really trying to change the way they do business every day? Employee retention rates hit a record low in March 2020.

Pharma 215
article thumbnail

Endometriosis market projected to grow at a CAGR of 10% between 2020 and 2030

Pharmaceutical Technology

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.

article thumbnail

MHRA warns of serious eye-related adverse events after Dupixent use

Pharmaceutical Technology

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

article thumbnail

Meningitis vaccine comes to the forefront with impressive study results

Pharmaceutical Technology

There was no significant difference in side effect profiles of the two vaccines, based on the data. The World Health Organization (WHO) has set a goal of ending the meningitis epidemic by 2030. The overall difference in seroresponses to the two vaccines for the four shared serogroups ranged from 1.2 for serogroup W to 20.5